Symbicort 160-4.5 MCG inhaler 10.2GM
Ended Awarded
- Contract number
- SPE2DB25FJLFU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,776
Award facts
- Contract value 100% obligated
- $12,776.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,776.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Symbicort 160-4.5 microgram inhalers (10.2 grams). The contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to issue orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for Defense Logistics Agency contracts. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare facilities. The Symbicort order represents one of numerous delivery orders the company fulfills under its master contract, which encompasses prescription medications, vaccines, specialty pharmaceuticals, and medical supplies essential to military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FJLFU?
SPE2DB25FJLFU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FJLFU worth?
The government has obligated $12,776 on SPE2DB25FJLFU.
Is contract SPE2DB25FJLFU an order under another contract?
Yes. SPE2DB25FJLFU is a delivery order under SPE2DB24D9802, an indefinite delivery contract.
Was contract SPE2DB25FJLFU competed?
The extent of competition for SPE2DB25FJLFU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award